| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LXRX | LEXICON PHARMACEUTICALS, INC. | Artal International Management S.A. | Director | Mar 13, 2024 | Option Exercise | $108.50 | 1,150,922 | 124,875,037 | 1,150,922 | Mar 13, 2024, 09:22 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Finance and Accounting | Feb 28, 2024 | Option Exercise | $2.62 | 11,793 | 30,898 | 47,800 | Feb 29, 2024, 04:33 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | President and CFO | Feb 28, 2024 | Option Exercise | $2.62 | 37,691 | 98,750 | 324,214 | Feb 29, 2024, 04:32 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | McDermott Wendy | VP, Human Resources | Feb 28, 2024 | Option Exercise | $2.62 | 22,425 | 58,753 | 52,694 | Feb 29, 2024, 04:31 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov & Chem Sciences | Feb 28, 2024 | Option Exercise | $2.62 | 24,408 | 63,949 | 255,724 | Feb 29, 2024, 04:30 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | Feb 28, 2024 | Option Exercise | $2.62 | 24,353 | 63,805 | 162,672 | Feb 29, 2024, 04:29 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Granowitz Craig B | SVP, Chief Medical Officer | Feb 28, 2024 | Option Exercise | $2.62 | 31,265 | 81,914 | 47,626 | Feb 29, 2024, 04:28 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Crum Brian T | SVP, General Counsel & Secr. | Feb 28, 2024 | Option Exercise | $2.62 | 25,604 | 67,082 | 177,497 | Feb 29, 2024, 04:27 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | Chief Executive Officer | Feb 28, 2024 | Option Exercise | $2.62 | 61,371 | 160,792 | 1,098,068 | Feb 29, 2024, 04:26 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | Chief Executive Officer | Nov 16, 2023 | Buy | $1.05 | 90,000 | 94,797 | 914,359 | Nov 17, 2023, 04:55 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Amouyal Philippe | Director | Nov 13, 2023 | Buy | $1.01 | 200,000 | 201,520 | 240,332 | Nov 14, 2023, 04:12 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | Chief Executive Officer | Nov 10, 2023 | Buy | $1.01 | 10,000 | 10,100 | 824,359 | Nov 13, 2023, 05:31 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | Oct 10, 2023 | Buy | $1.14 | 508,306 | 579,367 | 849,153 | Oct 12, 2023, 04:01 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | Oct 11, 2023 | Buy | $1.08 | 342,874 | 370,784 | 1,192,027 | Oct 12, 2023, 04:01 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | Oct 12, 2023 | Buy | $1.03 | 148,820 | 153,805 | 1,340,847 | Oct 12, 2023, 04:01 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | President and CFO | Sep 14, 2023 | Buy | $1.38 | 10,000 | 13,800 | 264,341 | Sep 14, 2023, 05:05 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | McDermott Wendy | VP, Human Resources | Aug 04, 2023 | Buy | $1.84 | 6,000 | 11,040 | 28,478 | Aug 07, 2023, 04:13 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | Chief Executive Officer | Jun 29, 2023 | Buy | $2.16 | 10,000 | 21,600 | 814,359 | Jun 29, 2023, 04:13 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | McDermott Wendy | VP, Human Resources | Jun 23, 2023 | Buy | $2.43 | 10,000 | 24,300 | 22,478 | Jun 27, 2023, 04:22 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | Chief Executive Officer | Jun 23, 2023 | Buy | $2.49 | 10,000 | 24,950 | 794,359 | Jun 26, 2023, 04:04 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | Chief Executive Officer | Jun 26, 2023 | Buy | $2.18 | 10,000 | 21,792 | 804,359 | Jun 26, 2023, 04:04 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | Chief Executive Officer | Jun 22, 2023 | Buy | $2.31 | 40,000 | 92,400 | 784,359 | Jun 22, 2023, 04:01 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | President and CFO | Jun 20, 2023 | Buy | $2.33 | 12,000 | 28,000 | 254,341 | Jun 20, 2023, 04:10 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Public Equities Advisors, LLC | Director | Jun 05, 2023 | Buy | $2.60 | 27,775,050 | 72,215,127 | 78,634,381 | Jun 05, 2023, 04:46 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Finance and Accounting | Feb 28, 2023 | Option Exercise | $2.17 | 5,330 | 11,566 | 30,350 | Mar 01, 2023, 04:56 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Seth Kiernan | VP, Chief Commercial Officer | Feb 28, 2023 | Option Exercise | $2.17 | 11,813 | 25,634 | 53,136 | Mar 01, 2023, 04:55 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | McDermott Wendy | VP, Human Resources | Feb 28, 2023 | Option Exercise | $2.17 | 6,465 | 14,029 | 12,478 | Mar 01, 2023, 04:54 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov & Chem Sciences | Feb 28, 2023 | Option Exercise | $2.17 | 20,946 | 45,453 | 212,586 | Mar 01, 2023, 04:53 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | Feb 28, 2023 | Option Exercise | $2.17 | 19,118 | 41,486 | 119,625 | Mar 01, 2023, 04:51 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Granowitz Craig B | SVP, Chief Medical Officer | Feb 28, 2023 | Option Exercise | $2.17 | 12,732 | 27,628 | 15,185 | Mar 01, 2023, 04:50 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Crum Brian T | SVP, General Counsel & Secr. | Feb 28, 2023 | Option Exercise | $2.17 | 20,537 | 44,565 | 134,798 | Mar 01, 2023, 04:49 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | President and CFO | Feb 28, 2023 | Option Exercise | $2.17 | 30,255 | 65,653 | 242,341 | Mar 01, 2023, 04:48 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | Chief Executive Officer | Feb 28, 2023 | Option Exercise | $2.17 | 50,971 | 110,607 | 744,359 | Mar 01, 2023, 04:46 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Ulys, L.L.C. | Director | Aug 05, 2022 | Buy | $2.50 | 147,390 | 368,475 | 5,451,204 | Aug 09, 2022, 04:48 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Westend S.A. | Director | Aug 05, 2022 | Buy | $2.50 | 2,426,070 | 6,065,175 | 50,859,331 | Aug 09, 2022, 04:46 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Public Equities Advisors, LLC | Director | Aug 01, 2022 | Buy | $2.50 | 16,173,800 | 40,434,500 | 48,433,261 | Aug 01, 2022, 04:15 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Ulys, L.L.C. | Director | Aug 01, 2022 | Buy | $2.50 | 982,600 | 2,456,500 | 5,303,814 | Aug 01, 2022, 04:15 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | Aug 01, 2022 | Buy | $2.50 | 982,600 | 2,456,500 | 5,303,814 | Aug 01, 2022, 04:13 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Alexander Kristen | VP, Finance and Accounting | Feb 28, 2022 | Option Exercise | $2.85 | 3,337 | 9,510 | 16,963 | Feb 28, 2022, 07:18 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Seth Kiernan | VP, Chief Commercial Officer | Feb 28, 2022 | Option Exercise | $2.85 | 8,261 | 23,544 | 21,867 | Feb 28, 2022, 07:17 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov & Chem Sciences | Feb 28, 2022 | Option Exercise | $2.85 | 19,756 | 56,305 | 175,589 | Feb 28, 2022, 07:16 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | Feb 28, 2022 | Option Exercise | $2.85 | 13,241 | 37,737 | 85,857 | Feb 28, 2022, 07:15 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Crum Brian T | SVP, General Counsel & Secr. | Feb 28, 2022 | Option Exercise | $2.85 | 15,059 | 42,918 | 99,458 | Feb 28, 2022, 07:13 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | President and CFO | Feb 28, 2022 | Option Exercise | $2.85 | 25,773 | 73,453 | 193,680 | Feb 28, 2022, 07:12 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | Chief Executive Officer | Feb 28, 2022 | Option Exercise | $2.85 | 48,053 | 136,951 | 586,003 | Feb 28, 2022, 07:11 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Tessmer James F | VP, Finance & Accounting | Mar 15, 2021 | Option Exercise | $5.68 | 34,912 | 198,160 | 83,766 | Mar 16, 2021, 07:45 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Feb 28, 2021 | Option Exercise | $7.19 | 26,584 | 191,139 | 157,020 | Mar 02, 2021, 05:01 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | President and CEO | Feb 28, 2021 | Option Exercise | $7.19 | 55,038 | 395,723 | 436,713 | Mar 02, 2021, 12:00 AM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Innov & Chem Sciences | Feb 28, 2021 | Option Exercise | $7.19 | 20,413 | 146,769 | 140,695 | Mar 02, 2021, 12:00 AM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Crum Brian T | VP, General Counsel & Secr. | Feb 28, 2021 | Option Exercise | $7.19 | 14,860 | 106,843 | 73,637 | Mar 02, 2021, 12:00 AM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | TYLE PRAVEEN | EVP, R&D | Feb 28, 2021 | Option Exercise | $7.19 | 16,560 | 119,066 | 120,791 | Mar 02, 2021, 12:00 AM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Tessmer James F | VP, Finance & Accounting | Feb 28, 2021 | Option Exercise | $7.19 | 10,765 | 77,400 | 82,678 | Mar 02, 2021, 12:00 AM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Westend S.A. | Director | Dec 16, 2020 | Buy | $3.20 | 10,937,500 | 35,000,001 | 32,259,461 | Dec 17, 2020, 02:43 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Public Equities Advisors, LLC | Director | Dec 16, 2020 | Buy | $3.20 | 10,937,500 | 35,000,001 | 32,259,461 | Dec 17, 2020, 02:39 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Apr 22, 2020 | Option Exercise | $1.96 | 9,651 | 18,916 | 115,495 | Apr 24, 2020, 05:24 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | TYLE PRAVEEN | EVP, R&D | Apr 22, 2020 | Option Exercise | $1.96 | 4,844 | 9,494 | 69,344 | Apr 24, 2020, 05:20 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Tessmer James F | VP, Finance & Accounting | Apr 22, 2020 | Option Exercise | $1.96 | 3,997 | 7,834 | 65,127 | Apr 24, 2020, 05:15 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Santini Alexander A | EVP and CCO | Apr 22, 2020 | Option Exercise | $1.96 | 6,813 | 13,353 | 55,584 | Apr 24, 2020, 05:12 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Commercial Supply Ops | Apr 22, 2020 | Option Exercise | $1.96 | 6,813 | 13,353 | 104,640 | Apr 24, 2020, 05:08 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Crum Brian T | VP, General Counsel & Secr. | Apr 22, 2020 | Option Exercise | $1.96 | 6,398 | 12,540 | 49,732 | Apr 24, 2020, 05:05 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Lapuerta Pablo | EVP and CMO | Apr 22, 2020 | Option Exercise | $1.96 | 6,813 | 13,353 | 85,719 | Apr 24, 2020, 05:02 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Santini Alexander A | EVP and CCO | Feb 28, 2020 | Option Exercise | $2.77 | 12,420 | 34,403 | 42,504 | Mar 03, 2020, 04:16 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Lapuerta Pablo | EVP and CMO | Feb 28, 2020 | Option Exercise | $2.77 | 13,305 | 36,855 | 72,639 | Mar 03, 2020, 04:15 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Commercial Supply Ops | Feb 28, 2020 | Option Exercise | $2.77 | 12,759 | 35,342 | 91,560 | Mar 03, 2020, 04:13 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Crum Brian T | VP, General Counsel & Secr. | Feb 28, 2020 | Option Exercise | $2.77 | 6,940 | 19,224 | 36,237 | Mar 03, 2020, 04:12 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | President and CEO | Feb 28, 2020 | Option Exercise | $2.77 | 45,320 | 125,536 | 298,866 | Mar 03, 2020, 04:11 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Feb 28, 2020 | Option Exercise | $2.77 | 16,025 | 44,389 | 98,621 | Mar 03, 2020, 12:00 AM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Tessmer James F | VP, Finance & Accounting | Feb 28, 2020 | Option Exercise | $2.77 | 3,902 | 10,809 | 55,862 | Mar 03, 2020, 12:00 AM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | President and CEO | Sep 18, 2019 | Buy | $3.10 | 50,000 | 155,000 | 227,539 | Sep 19, 2019, 04:28 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Santini Alexander A | EVP and CCO | Sep 18, 2019 | Buy | $3.36 | 4,500 | 15,115 | 18,661 | Sep 19, 2019, 04:26 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | President and CEO | Sep 17, 2019 | Buy | $3.13 | 50,000 | 156,403 | 177,539 | Sep 18, 2019, 04:39 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | Sep 13, 2019 | Buy | $2.46 | 9,269 | 22,806 | 219,644 | Sep 17, 2019, 05:36 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | Sep 16, 2019 | Buy | $2.72 | 93,773 | 254,785 | 313,417 | Sep 17, 2019, 05:36 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | DEBBANE RAYMOND | Director | Sep 13, 2019 | Buy | $2.40 | 197,473 | 474,760 | 210,375 | Sep 17, 2019, 05:33 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | SOBECKI CHRISTOPHER J | Director | Sep 16, 2019 | Buy | $2.55 | 25,000 | 63,718 | 137,293 | Sep 17, 2019, 05:27 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | SOBECKI CHRISTOPHER J | Director | Sep 13, 2019 | Buy | $2.41 | 99,249 | 238,750 | 112,293 | Sep 17, 2019, 05:23 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | President and CEO | Aug 16, 2019 | Buy | $1.35 | 37,000 | 49,835 | 124,539 | Aug 20, 2019, 05:02 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | President and CEO | Aug 19, 2019 | Buy | $1.40 | 3,000 | 4,194 | 127,539 | Aug 20, 2019, 05:02 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Tessmer James F | VP, Finance & Accounting | Aug 02, 2019 | Buy | $1.14 | 10,000 | 11,400 | 43,368 | Aug 02, 2019, 04:15 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | BARKER SAM L | Director | Aug 02, 2019 | Buy | $1.17 | 24,000 | 28,200 | 52,187 | Aug 02, 2019, 04:12 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | WADE JEFFREY L | EVP, Corp Adm Affairs and CFO | Feb 28, 2019 | Option Exercise | $5.51 | 8,639 | 47,601 | 72,508 | Mar 01, 2019, 05:20 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Tessmer James F | VP, Finance & Accounting | Feb 28, 2019 | Option Exercise | $5.51 | 2,501 | 13,781 | 33,368 | Mar 01, 2019, 05:18 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Santini Alexander A | EVP and CCO | Feb 28, 2019 | Option Exercise | $5.51 | 4,544 | 25,037 | 14,161 | Mar 01, 2019, 05:18 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | MAIN ALAN J | EVP, Commercial Supply Ops | Feb 28, 2019 | Option Exercise | $5.51 | 6,885 | 37,936 | 67,067 | Mar 01, 2019, 05:17 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Lapuerta Pablo | EVP and CMO | Feb 28, 2019 | Option Exercise | $5.51 | 6,809 | 37,518 | 47,098 | Mar 01, 2019, 05:16 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | COATS LONNEL | President and CEO | Feb 28, 2019 | Option Exercise | $5.51 | 18,641 | 102,712 | 87,539 | Mar 01, 2019, 05:15 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Advisors, L.L.C. | Director | Jun 27, 2018 | Buy | $12.54 | 125,114 | 1,568,442 | 3,458,490 | Jun 29, 2018, 04:23 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Advisors, L.L.C. | Director | Jun 28, 2018 | Buy | $12.45 | 57,724 | 718,935 | 3,516,214 | Jun 29, 2018, 04:23 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus, L.P. | Director | Jun 25, 2018 | Buy | $12.95 | 228,264 | 2,955,083 | 3,333,376 | Jun 26, 2018, 05:32 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Artal International Management S.A. | Director | Jun 22, 2018 | Buy | $13.36 | 25,461 | 340,090 | 3,105,112 | Jun 26, 2018, 05:32 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Advisors, L.L.C. | Director | Jun 19, 2018 | Buy | $13.45 | 8,982 | 120,819 | 3,015,660 | Jun 21, 2018, 05:55 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Stichting Administratiekantoor Westend | Director | Jun 20, 2018 | Buy | $13.28 | 12,391 | 164,613 | 3,028,051 | Jun 21, 2018, 05:55 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Advisors, L.L.C. | Director | Jun 21, 2018 | Buy | $13.27 | 51,600 | 684,613 | 3,079,651 | Jun 21, 2018, 05:55 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Public Equities Advisors, LLC | Director | Jun 18, 2018 | Buy | $13.06 | 36,584 | 477,937 | 3,006,678 | Jun 18, 2018, 06:56 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Westend S.A. | Director | Jun 14, 2018 | Buy | $12.66 | 9,200 | 116,462 | 2,970,094 | Jun 18, 2018, 06:56 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Public Equities Advisors, LLC | Director | Jun 08, 2018 | Buy | $12.89 | 29,747 | 383,427 | 2,755,245 | Jun 12, 2018, 06:10 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Artal Group S.A. | Director | Jun 11, 2018 | Buy | $12.75 | 98,626 | 1,257,452 | 2,853,871 | Jun 12, 2018, 06:10 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Advisors, L.L.C. | Director | Jun 12, 2018 | Buy | $12.83 | 107,023 | 1,373,244 | 2,960,894 | Jun 12, 2018, 06:10 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Tessmer James F | VP, Finance & Accounting | Jun 08, 2018 | Option Exercise | $11.53 | 20,000 | 230,576 | 35,643 | Jun 12, 2018, 04:37 PM | |
| LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Public Equities Advisors, LLC | Director | Jun 05, 2018 | Buy | $12.45 | 173,121 | 2,156,187 | 2,572,980 | Jun 07, 2018, 07:37 PM |
Menu